Duan Ma Selected Research

Thrombosis (Thrombus)

9/2017	Endogenous tissue factor pathway inhibitor in vascular smooth muscle cells inhibits arterial thrombosis.
1/2006	Exogenous tissue plasminogen activator enhances peripheral nerve regeneration and functional recovery after injury in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Duan Ma Research Topics

Disease

21	Neoplasms (Cancer) 11/2023 - 02/2004
10	Tetralogy of Fallot (Fallot Tetralogy) 01/2022 - 05/2012
10	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2004
6	Carcinogenesis 01/2021 - 03/2013
6	Hearing Loss (Hearing Impairment) 10/2019 - 01/2013
5	Pre-Eclampsia (Preeclampsia) 01/2022 - 06/2010
5	Congenital Heart Defects (Congenital Heart Defect) 02/2021 - 07/2010
5	Ovarian Neoplasms (Ovarian Cancer) 02/2015 - 10/2009
4	Congenital Microtia 12/2023 - 04/2013
4	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 10/2016
4	Inflammation (Inflammations) 04/2022 - 06/2005
4	Gaucher Disease (Gaucher's Disease) 01/2022 - 01/2015
4	Malignant Fibrous Histiocytoma 03/2018 - 01/2015
4	Atherosclerosis 02/2017 - 01/2009
4	Breast Neoplasms (Breast Cancer) 03/2013 - 12/2007
3	Obesity 04/2022 - 09/2006
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2012
3	Neuroblastoma 10/2020 - 11/2016
3	Proteinuria 06/2020 - 06/2015
3	Down Syndrome (Down's Syndrome) 07/2014 - 02/2011
3	Glomerulonephritis 03/2010 - 11/2008
2	Wounds and Injuries (Trauma) 04/2024 - 08/2011
2	Cleft Lip (Harelip) 01/2023 - 01/2021
2	Body Weight (Weight, Body) 04/2022 - 01/2013
2	Osteoporosis 01/2022 - 11/2021
2	Chronic Renal Insufficiency 01/2022 - 11/2019
2	Vascular Diseases (Vascular Disease) 01/2022 - 09/2017
2	Hepatoblastoma 01/2021 - 12/2020
2	Hypertension (High Blood Pressure) 06/2020 - 02/2017
2	Thrombosis (Thrombus) 09/2017 - 01/2006
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2015 - 08/2014
2	Atherosclerotic Plaque (Atheroma) 09/2013 - 08/2011
2	Deafness (Deaf Mutism) 04/2013 - 12/2011
2	Fibrosarcoma 01/2012 - 02/2004
2	Insulin Resistance 03/2011 - 10/2009
2	Ovarian Epithelial Carcinoma 09/2010 - 10/2009
1	Endotoxemia 04/2022
1	Alveolar Bone Loss 04/2022
1	Periodontitis 04/2022
1	Type 2 Diabetes Mellitus (MODY) 04/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2022
1	Hypoxia (Hypoxemia) 01/2022

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 05/2022 - 12/2007
13	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2008
8	Long Noncoding RNAIBA 01/2022 - 03/2017
8	lipoprotein-associated coagulation inhibitor (TFPI)IBA 09/2017 - 06/2005
8	tissue-factor-pathway inhibitor 2 (PP5)IBA 10/2015 - 02/2004
6	Messenger RNA (mRNA)IBA 05/2022 - 12/2007
6	Thromboplastin (Tissue Factor)IBA 02/2017 - 02/2004
6	DNA (Deoxyribonucleic Acid)IBA 07/2014 - 12/2007
5	RNA (Ribonucleic Acid)IBA 11/2023 - 10/2016
5	Mitochondrial DNA (mtDNA)IBA 01/2022 - 03/2011
4	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 01/2012
4	EnzymesIBA 01/2022 - 01/2011
4	3' Untranslated Regions (3' UTR)IBA 01/2017 - 03/2011
3	AcidsIBA 12/2023 - 05/2014
3	Glucosylceramidase (Glucocerebrosidase)IBA 01/2022 - 05/2016
3	CateninsIBA 01/2022 - 02/2014
3	Histones (Histone)IBA 11/2021 - 07/2010
3	Biomarkers (Surrogate Marker)IBA 11/2021 - 07/2009
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 03/2012
3	Interleukin-6 (Interleukin 6)IBA 03/2018 - 10/2009
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 01/2015
3	Matrix Metalloproteinases (MMPs)IBA 09/2013 - 02/2004
2	AdiponectinIBA 04/2022 - 10/2009
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022 - 06/2018
2	LuciferasesIBA 01/2022 - 12/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 02/2004
2	ChromatinIBA 11/2021 - 12/2007
2	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2013
2	Phosphates (Orthophosphate)IBA 08/2019 - 10/2009
2	CytokinesIBA 03/2018 - 01/2017
2	Hemostatics (Antihemorrhagics)IBA 09/2017 - 01/2011
2	Apolipoproteins E (ApoE)IBA 02/2017 - 09/2013
2	Glucosylceramides (Glucocerebrosides)IBA 05/2016 - 01/2015
2	Ethanol (Ethyl Alcohol)IBA 11/2015 - 06/2014
2	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 03/2013 - 01/2012
2	LipidsIBA 12/2010 - 01/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2009 - 01/2008
2	Fibrinolysin FDA Link 12/2007 - 02/2004
2	Enzyme Precursors (Zymogens)IBA 12/2007 - 02/2004
2	TrypsinIBA 12/2007 - 02/2004
1	Cell-Free Nucleic AcidsIBA 04/2024
1	3-(2'-pyridyldithio)benzyldiazoacetate (MPDA)IBA 04/2024
1	Circular RNAIBA 12/2023
1	ChitosanIBA 12/2023
1	Immunoglobulin A (IgA)IBA 11/2023
1	hydrogen sulfite (bisulfite)IBA 01/2023
1	Apolipoprotein C-II (ApoC2)IBA 05/2022
1	Blood Glucose (Blood Sugar)IBA 04/2022
1	AdipoRonIBA 04/2022
1	Adiponectin ReceptorsIBA 04/2022
1	Hormones (Hormone)IBA 04/2022
1	Annexin A2 (Annexin II)IBA 01/2022
1	Hypoxia-Inducible Factor 1IBA 01/2022
1	Deubiquitinating EnzymesIBA 01/2022
1	Profilins (Profilin)IBA 01/2022
1	TensinsIBA 01/2022

Therapy/Procedure

3	Therapeutics 01/2019 - 01/2015
2	Lasers (Laser) 01/2012 - 10/2009